Emscher

The Emscher is a river, a tributary of the Rhine, that flows through the Ruhr area in North Rhine-Westphalia in western Germany. Its overall length is 83 kilometres (52 mi) with an mean outflow near the mouth into the lower Rhine of 16 m3/s (570 cu ft/s).

Emscher
The Emscher in southern Dortmund
Location
CountryGermany
Physical characteristics
SourceHolzwickede
  locationEastern Ruhr Area
  elevation160 m (520 ft)
MouthRhine
  coordinates
51°33′48″N 6°41′23″E
Length83.2 km (51.7 mi) [1]
Basin size793 km2 (306 sq mi) [1]
Discharge 
  average16 m3/s (570 cu ft/s)
Basin features
ProgressionRhineNorth Sea

Description

The Emscher has its wellspring in Holzwickede, east of the city of Dortmund. Towns along the Emscher are Dortmund, Castrop-Rauxel, Herne, Recklinghausen, Gelsenkirchen, Essen, Bottrop, Oberhausen and Dinslaken, where it flows into the Rhine.

At the centre of a vast industrial area with 5 million inhabitants the river is biologically dead, as it was used as an open waste-water canal from the end of the 19th century. The partial collapse of many coal mines along the Emscher's route made the option of subterranean sewer pipes running alongside unworkable, as they would break too easily.

Owing to the steady flow of spoil from the mining industry it has been impossible for the route of the Emscher to be maintained and its mouth into the Rhine has shifted north twice. A large wastewater treatment plant at its mouth treats the water of the Emscher before it flows into the Rhine.

Restoration

Since the early 1990s, efforts to restore the Emscher to its natural state have been making headway. The last coal mine (Bergwerk Prosper-Haniel) was closed in December 2018. Now that coal mining near the route of the river has halted, a large underground pipe is being built along the path of the river. The first stretch of the river to be restored is that in the city of Dortmund. The overall project is headed by the public water board Emschergenossenschaft. The financial cost is estimated to be 4.5 billion Euro and the expected completion date for the main work is 2020.[2]

gollark: The annoying thing is that, regardless of whether the mRNA ones *are* actually bad at all, with wide enough deployment someone will get a heart attack or something after getting it due to sheer random chance and people will start complaining.
gollark: I mean, "logically" it shouldn't do awful things, sure, but immunology and biology in general are hellishly complex and unpredictable.
gollark: https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease says it's 50%ish.
gollark: Hold on, checking.
gollark: I heard the survival rate's better in developed countries, around 60%.

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.